• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protagenic Therapeutics, Inc. - Common Stock (NQ:PTIX)

0.7400 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7400
Bid (Size) 0.4400 (20,000)
Ask (Size) 0.4999 (6,200)
Prev. Close 0.7400
Today's Range 0.7400 - 0.7400
52wk Range 0.2039 - 14.28
Shares Outstanding 1,810,208
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
April 23, 2026
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
March 17, 2026
Via ACCESS Newswire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-75.2%
-75.2%
1 Year
+239.3%
+239.3%

More News

Read More
News headline image
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
March 10, 2026
Via ACCESS Newswire
Wondering what's happening in today's after-hours session? ↗
January 05, 2026
Via Chartmill
News headline image
Results from Phase 1 Multiple-Dose Study of PT00114
December 09, 2025
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
November 13, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 13, 2025
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
August 25, 2025
Via Chartmill
News headline image
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
August 22, 2025
Via ACCESS Newswire
News headline image
Wondering what's happening in today's pre-market session? ↗
August 22, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 22, 2025
Via Benzinga
News headline image
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress ↗
August 21, 2025
Via Benzinga
News headline image
Top stock movements in today's session. ↗
August 21, 2025
Via Chartmill
News headline image
These stocks are making the most noise in today's session. ↗
August 21, 2025
Via Chartmill
News headline image
S&P 500 Moves Lower; Walmart Shares Fall After Q2 Results ↗
August 21, 2025
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 21, 2025
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session. ↗
August 21, 2025
Via Chartmill
News headline image
Dow Dips Over 100 Points; US Initial Jobless Claims Increase ↗
August 21, 2025
Via Benzinga
Topics Stocks
News headline image
These stocks that are showing activity before the opening bell on Thursday. ↗
August 21, 2025
Via Chartmill
News headline image
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
August 21, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 30, 2025
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
July 08, 2025
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders
May 27, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)
May 27, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
May 21, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Protagenic Therapeutics, Inc. - Common Stock publicly traded?
Yes, Protagenic Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Protagenic Therapeutics, Inc. - Common Stock trade on?
Protagenic Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Protagenic Therapeutics, Inc. - Common Stock?
The ticker symbol for Protagenic Therapeutics, Inc. - Common Stock is PTIX on the Nasdaq Stock Market
What is the current price of Protagenic Therapeutics, Inc. - Common Stock?
The current price of Protagenic Therapeutics, Inc. - Common Stock is 0.7400
When was Protagenic Therapeutics, Inc. - Common Stock last traded?
The last trade of Protagenic Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Protagenic Therapeutics, Inc. - Common Stock?
The market capitalization of Protagenic Therapeutics, Inc. - Common Stock is 1.34M
How many shares of Protagenic Therapeutics, Inc. - Common Stock are outstanding?
Protagenic Therapeutics, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap